February 2011 Briefing - Pain Management

Here are what the editors at HealthDay consider to be the most important developments in Pain Management for February 2011. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

Cochrane Review Examines Safety of Biologic Agents

MONDAY, Feb. 28 (HealthDay News) -- Patients taking biologic agents for rheumatoid arthritis and other inflammatory conditions may experience a higher rate of adverse events, withdrawals from studies due to adverse events, and tuberculosis reactivation, compared to placebo, according to a literature review published online Feb. 16 in the Cochrane Database of Systematic Reviews.

Abstract
Full Text (subscription or payment may be required)

Definitions of Rheumatoid Arthritis Remission Proposed

FRIDAY, Feb. 25 (HealthDay News) -- The American College of Rheumatology and the European League Against Rheumatism have developed two provisional definitions of remission in rheumatoid arthritis that can be applied uniformly and used as outcome measures in clinical trials, according to an article published in the March issue of Arthritis & Rheumatism.

Abstract
Full Text (subscription or payment may be required)

Equations Predict Quadriceps Strength in Knee Osteoarthritis

THURSDAY, Feb. 24 (HealthDay News) -- Predictive equations can be used to assess maximal quadriceps strength in individuals who have osteoarthritis in a knee joint, according to a study published in the February issue of Arthritis Care & Research.

Abstract
Full Text (subscription or payment may be required)

Herpes Zoster Risk Tied to COPD

WEDNESDAY, Feb. 23 (HealthDay News) -- Patients suffering from chronic obstructive pulmonary disease (COPD), especially those using oral steroids, are at increased risk of developing herpes zoster, according to a study published online Feb. 22 in CMAJ, the journal of the Canadian Medical Association.

Abstract
Full Text

Kyphoplasty Effective for Vertebral Fractures

MONDAY, Feb. 21 (HealthDay News) -- Balloon kyphoplasty appears to be a safe and effective means for reducing pain and improving function in cancer patients with vertebral compression fractures (VCFs), according to research published online Feb. 17 in The Lancet Oncology.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Fostamatinib Safe, Not Effective in Rheumatoid Arthritis

MONDAY, Feb. 21 (HealthDay News) -- Fostamatinib disodium (R788), an oral spleen tyrosine kinase inhibitor, is safe but ineffective for treatment of patients with rheumatoid arthritis (RA) who failed biologic therapies, according to a study published in the February issue of Arthritis & Rheumatism.

Abstract
Full Text (subscription or payment may be required)

Low Pay for New Female Doctors Tied to Gender, Not Job

MONDAY, Feb. 21 (HealthDay News) -- In 2008, male physicians who were newly trained in New York State made an average of $16,819 more than newly trained female physicians, compared to a $3,600 difference in 1999, according to a study published in the February issue of Health Affairs.

Abstract
Full Text (subscription or payment may be required)

Different Therapies Improve Chronic Fatigue Outcomes

FRIDAY, Feb. 18 (HealthDay News) -- For chronic fatigue patients, cognitive behavior therapy (CBT) and graded exercise therapy (GET) may moderately improve outcomes when added to specialist medical care (SMC), according to research published online Feb. 18 in The Lancet.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Insomnia in Arthritis Tied to Pain, Depression Ups Risk

FRIDAY, Feb. 18 (HealthDay News) -- Sleep disturbances are more prevalent among adults with arthritis compared to those without the disease, with the greatest risk affecting those with anxiety and depression, according to a study published in the February issue of Arthritis Care & Research.

Abstract
Full Text (subscription or payment may be required)

Analgesic Efficacy Altered by Patient Beliefs

THURSDAY, Feb. 17 (HealthDay News) -- An individual's expectation of a drug's effect influences both its therapeutic efficacy and the pain-related brain pathways that are activated during treatment, according to a study published in the Feb. 16 issue of Science Translational Medicine.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

New U.S. Report on the Nation's Health 2010 Released

WEDNESDAY, Feb. 16 (HealthDay News) -- The U.S. Centers for Disease Control and Prevention's National Center for Health Statistics' 34th annual report, presenting the latest information on health status and determinants, utilization of health care, health care resources, expenditures, and a special feature on death and dying, was published Feb. 16.

More Information

Most Recalled Medical Devices Given Lenient Approval

TUESDAY, Feb. 15 (HealthDay News) -- The majority of medical devices recalled from 2005 to 2009 for risk of serious health hazard or death were approved by the less strict 510(k) process intended for devices considered low or moderate risk, according to a study published online Feb. 14 in the Archives of Internal Medicine.

Abstract
Full Text
Editorial

High Body Mass Index Linked to Poor Infliximab Response

TUESDAY, Feb. 15 (HealthDay News) -- Patients suffering from rheumatoid arthritis (RA) who have a high body mass index (BMI) respond less well to infliximab, even when adjusting for disease activity and anti-citrullinated protein antibody status, according to a study published in the February issue of Arthritis & Rheumatism.

Abstract
Full Text (subscription or payment may be required)

Researchers Explore Nature of Difficult Clinical Encounters

MONDAY, Feb. 14 (HealthDay News) -- Both patients and physicians can bring qualities to a clinical encounter that result in its being perceived as difficult, and patients involved in these types of encounters have worse short-term outcomes, according to research published online Jan. 25 in the Journal of General Internal Medicine.

Abstract
Full Text (subscription or payment may be required)

Addison's Disease Is a Risk Factor for Hip Fracture

FRIDAY, Feb. 11 (HealthDay News) -- Clinically diagnosed and undiagnosed cases of Addison's disease (AD) are associated with hip fractures in patients aged 30 years or older, with the highest risk in women aged 50 years or younger, according to a study published online Jan. 19 in the Journal of Internal Medicine.

Abstract
Full Text (subscription or payment may be required)

Surgery for Migraines Has Long-Lasting Positive Impact

FRIDAY, Feb. 11 (HealthDay News) -- Long-term follow-up indicates that surgical manipulation of migraine trigger sites can reduce the frequency, duration, and intensity of migraines, according to a study published in the February issue of Plastic and Reconstructive Surgery.

Abstract
Full Text (subscription or payment may be required)

Public Sector Plays Big Role in Drug Research

WEDNESDAY, Feb. 9 (HealthDay News) -- Public-sector research institutions (PSRIs) appear to play a bigger role in drug discovery than was previously thought, contributing to the discovery of about 10 to 20 percent of drugs approved for new drug applications since 1990, according to research published in the Feb. 10 issue of the New England Journal of Medicine.

Abstract
Full Text (subscription or payment may be required)

Errors in Hospital Analgesia Prescriptions Nearly 3 in 1,000

WEDNESDAY, Feb. 9 (HealthDay News) -- Analgesic drug errors in hospitals occur at a rate of almost three per 1,000 prescriptions, and more than twice that among pediatric patients, according to a study published in the January issue of the Journal of Pain.

Abstract
Full Text (subscription or payment may be required)

Rheumatic Diseases Afflict 1 in 12 Women, 1 in 20 Men

WEDNESDAY, Feb. 9 (HealthDay News) -- About 8 percent of women and 5 percent of men will develop an inflammatory autoimmune rheumatic disease such as rheumatoid arthritis (RA) during their lifetime, according to research published online Dec. 28 in Arthritis & Rheumatism.

Abstract
Full Text

Surgery Reduces Leg Pain More Than Low Back Pain

TUESDAY, Feb. 8 (HealthDay News) -- Surgical treatment improves leg pain more than low back pain in patients with degenerative spondylolisthesis (DS) and spinal stenosis (SpS), according to a study published in the Feb. 1 issue of Spine.

Abstract
Full Text (subscription or payment may be required)

Data Collection Shows Fibromyalgia Symptoms Pattern

TUESDAY, Feb. 8 (HealthDay News) -- Longitudinal data collection by hand-held Ecological Momentary Assessment (EMA) devices, which record daily symptoms of fibromyalgia syndrome (FMS), reveals small but significant temporal relationships between pain, fatigue, and emotional distress, according to a study published in the January issue of the Journal of Pain.

Abstract
Full Text (subscription or payment may be required)

Age, Race, and Wealth Affect Arthritis Drug Receipt

TUESDAY, Feb. 1 (HealthDay News) -- Among Medicare-managed rheumatoid arthritis (RA) patients, receipt of disease-modifying antirheumatic drugs (DMARDs) varies based on demographic and other factors, according to a study published in the Feb. 2 issue of the Journal of the American Medical Association.

Abstract
Full Text (subscription or payment may be required)

Imaging for Low Back Pain Often Useless, Harmful

TUESDAY, Feb. 1 (HealthDay News) -- For most patients, routine imaging for low back pain is an expensive intervention that may do more harm than good, according to a clinical guideline published in the Feb. 1 issue of the Annals of Internal Medicine.

Abstract - Chou
Full Text (subscription or payment may be required)
Abstract - Owens
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Physician's Briefing

Updated on June 06, 2022

Read this Next
About UsOur ProductsCustom SolutionsHow it’s SoldOur ResultsDeliveryContact UsBlogPrivacy PolicyFAQ